CN Stock MarketDetailed Quotes

002014 Huangshan Novel

Watchlist
  • 11.91
  • +0.18+1.53%
Not Open Apr 1 15:00 CST
7.29BMarket Cap15.59P/E (TTM)

Huangshan Novel Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Total operating revenue
4.34%3.53B
2.44%2.54B
2.84%1.65B
6.34%834.98M
2.26%3.38B
3.76%2.48B
4.71%1.61B
8.45%785.19M
9.27%3.3B
11.92%2.39B
Operating revenue
4.34%3.53B
2.44%2.54B
2.84%1.65B
6.34%834.98M
2.26%3.38B
3.76%2.48B
4.71%1.61B
8.45%785.19M
9.27%3.3B
11.92%2.39B
Other operating revenue
8.20%110.68M
----
-19.15%56.16M
----
12.54%102.29M
----
64.49%69.47M
----
-14.40%90.9M
----
Total operating cost
4.02%3.03B
3.96%2.22B
4.78%1.47B
8.18%748.08M
-0.03%2.92B
1.74%2.14B
2.28%1.4B
6.06%691.53M
8.71%2.92B
11.00%2.1B
Operating cost
5.56%2.69B
4.96%1.96B
5.58%1.28B
9.65%650.75M
-0.98%2.55B
-0.13%1.86B
0.17%1.21B
3.47%593.49M
9.33%2.57B
13.05%1.87B
Operating tax surcharges
-19.33%23.92M
-24.64%16.3M
-20.05%11.88M
-20.45%6.53M
34.61%29.65M
53.16%21.63M
66.85%14.86M
74.18%8.21M
33.66%22.02M
16.50%14.12M
Operating expense
1.29%58.32M
-3.57%41.57M
9.24%31.35M
2.27%17.36M
2.08%57.58M
14.96%43.11M
14.87%28.7M
28.66%16.97M
2.90%56.4M
-25.06%37.5M
Administration expense
-6.65%120.03M
-8.73%90.9M
-6.07%64.26M
-2.12%37.83M
-3.08%128.57M
3.37%99.59M
6.81%68.41M
20.25%38.65M
-8.14%132.66M
-1.70%96.34M
Financial expense
-150.78%-5.01M
416.47%5.76M
65.06%2.02M
-611.11%-711.22K
2,294.70%9.87M
86.02%-1.82M
117.16%1.22M
108.05%139.15K
108.91%412.1K
-174.67%-13.02M
-Interest expense (Financial expense)
-34.15%12.15M
14.84%13.09M
30.33%9.88M
-52.29%1.37M
39.82%18.45M
20.19%11.39M
3.94%7.58M
-35.60%2.87M
60.86%13.2M
118.10%9.48M
-Interest Income (Financial expense)
49.71%-10.42M
35.15%-10.63M
-5.63%-8.64M
36.98%-3.01M
-93.64%-20.71M
4.77%-16.4M
35.01%-8.18M
33.81%-4.77M
23.11%-10.7M
-80.06%-17.22M
Research and development
2.86%149.14M
0.18%112.84M
3.93%74.28M
6.62%36.32M
7.42%145M
11.36%112.64M
10.40%71.47M
13.18%34.07M
11.46%134.98M
15.28%101.15M
Credit Impairment Loss
-22.17%-4.12M
50.46%-1.71M
78.10%-267.23K
79.47%-400.52K
-21.54%-3.38M
-1.99%-3.45M
-97.16%-1.22M
-376.96%-1.95M
-2,675.44%-2.78M
-262.11%-3.38M
Asset Impairment Loss
34.55%-21.2M
197.45%1.81M
89.30%-199.34K
----
-76.79%-32.39M
---1.86M
---1.86M
----
-80.08%-18.32M
----
Other net revenue
1,714.56%36.77M
377.87%44.02M
416.49%27.88M
4,094.64%15.36M
-112.42%-2.28M
-19.06%9.21M
-47.65%5.4M
-93.20%366.19K
11.92%18.34M
-9.96%11.38M
Fair value change income
257.82%7.1M
--3.03M
--2.03M
--1.25M
315.39%1.99M
----
----
----
-45.81%477.93K
----
Invest income
4.28%14.89M
42.75%9.06M
79.80%6.3M
2,083.07%3.35M
43.42%14.28M
469.62%6.35M
236.84%3.5M
21,442.94%153.45K
44.15%9.96M
200.91%1.11M
Asset deal income
----
----
----
----
-99.33%91.57K
40.48%-14.22K
-193.24%-15.01K
--21.94K
7,347.20%13.63M
-115.86%-23.89K
Other revenue
134.03%40.1M
288.54%31.83M
300.86%20.02M
421.16%11.16M
11.48%17.14M
-40.09%8.19M
-49.44%4.99M
-54.20%2.14M
-16.83%15.37M
4.75%13.67M
Operating profit
14.86%528.77M
3.07%359.82M
0.60%213.54M
8.75%102.26M
13.56%460.35M
17.16%349.1M
20.49%212.26M
21.56%94.03M
13.67%405.39M
17.76%297.97M
Add:Non operating Income
-23.32%2.12M
-1.64%1.63M
-25.10%773.91K
4.53%536.01K
-29.50%2.76M
-7.74%1.66M
-33.05%1.03M
-32.44%512.79K
-0.45%3.92M
65.39%1.8M
Less:Non operating expense
-62.46%790.67K
-37.67%821.26K
-36.58%712.32K
-75.88%246.82K
33.01%2.11M
264.82%1.32M
308.58%1.12M
536.50%1.02M
143.85%1.58M
41.14%361.15K
Total profit
14.99%530.09M
3.20%360.63M
0.68%213.6M
9.65%102.55M
13.07%461M
16.71%349.45M
19.58%212.17M
19.97%93.52M
13.28%407.73M
17.95%299.41M
Less:Income tax cost
25.80%58.83M
2.09%53.53M
-3.59%31.43M
4.27%14.95M
20.10%46.76M
14.33%52.43M
18.03%32.6M
22.28%14.34M
0.36%38.94M
24.48%45.86M
Net profit
13.77%471.26M
3.40%307.1M
1.45%182.17M
10.62%87.59M
12.32%414.24M
17.14%297.01M
19.87%179.57M
19.56%79.18M
14.85%368.79M
16.84%253.55M
Net profit from continuing operation
13.77%471.26M
3.40%307.1M
1.45%182.17M
10.62%87.59M
12.32%414.24M
17.14%297.01M
19.87%179.57M
19.56%79.18M
14.85%368.79M
16.84%253.55M
Less:Minority Profit
-43.34%3.51M
-42.95%2.26M
-21.33%2.01M
-4.59%1.17M
3.96%6.2M
13.05%3.96M
10.59%2.55M
16.80%1.23M
14.49%5.96M
6.73%3.5M
Net profit of parent company owners
14.63%467.75M
4.02%304.84M
1.78%180.17M
10.86%86.42M
12.46%408.05M
17.20%293.06M
20.01%177.02M
19.60%77.96M
14.85%362.83M
16.99%250.05M
Earning per share
Basic earning per share
13.43%0.76
4.17%0.5
0.00%0.29
7.69%0.14
11.67%0.67
14.29%0.48
16.00%0.29
8.33%0.13
15.38%0.6
0.00%0.42
Diluted earning per share
13.43%0.76
4.17%0.5
0.00%0.29
7.69%0.14
11.67%0.67
14.29%0.48
16.00%0.29
8.33%0.13
15.38%0.6
0.00%0.42
Other composite income
Total composite income
13.77%471.26M
3.40%307.1M
1.45%182.17M
10.62%87.59M
12.32%414.24M
17.14%297.01M
19.87%179.57M
19.56%79.18M
14.85%368.79M
16.84%253.55M
Total composite income of parent company owners
14.63%467.75M
4.02%304.84M
1.78%180.17M
10.86%86.42M
12.46%408.05M
17.20%293.06M
20.01%177.02M
19.60%77.96M
14.85%362.83M
16.99%250.05M
Total composite income of minority owners
-43.34%3.51M
-42.95%2.26M
-21.33%2.01M
-4.59%1.17M
3.96%6.2M
13.05%3.96M
10.59%2.55M
16.80%1.23M
14.49%5.96M
6.73%3.5M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Total operating revenue 4.34%3.53B2.44%2.54B2.84%1.65B6.34%834.98M2.26%3.38B3.76%2.48B4.71%1.61B8.45%785.19M9.27%3.3B11.92%2.39B
Operating revenue 4.34%3.53B2.44%2.54B2.84%1.65B6.34%834.98M2.26%3.38B3.76%2.48B4.71%1.61B8.45%785.19M9.27%3.3B11.92%2.39B
Other operating revenue 8.20%110.68M-----19.15%56.16M----12.54%102.29M----64.49%69.47M-----14.40%90.9M----
Total operating cost 4.02%3.03B3.96%2.22B4.78%1.47B8.18%748.08M-0.03%2.92B1.74%2.14B2.28%1.4B6.06%691.53M8.71%2.92B11.00%2.1B
Operating cost 5.56%2.69B4.96%1.96B5.58%1.28B9.65%650.75M-0.98%2.55B-0.13%1.86B0.17%1.21B3.47%593.49M9.33%2.57B13.05%1.87B
Operating tax surcharges -19.33%23.92M-24.64%16.3M-20.05%11.88M-20.45%6.53M34.61%29.65M53.16%21.63M66.85%14.86M74.18%8.21M33.66%22.02M16.50%14.12M
Operating expense 1.29%58.32M-3.57%41.57M9.24%31.35M2.27%17.36M2.08%57.58M14.96%43.11M14.87%28.7M28.66%16.97M2.90%56.4M-25.06%37.5M
Administration expense -6.65%120.03M-8.73%90.9M-6.07%64.26M-2.12%37.83M-3.08%128.57M3.37%99.59M6.81%68.41M20.25%38.65M-8.14%132.66M-1.70%96.34M
Financial expense -150.78%-5.01M416.47%5.76M65.06%2.02M-611.11%-711.22K2,294.70%9.87M86.02%-1.82M117.16%1.22M108.05%139.15K108.91%412.1K-174.67%-13.02M
-Interest expense (Financial expense) -34.15%12.15M14.84%13.09M30.33%9.88M-52.29%1.37M39.82%18.45M20.19%11.39M3.94%7.58M-35.60%2.87M60.86%13.2M118.10%9.48M
-Interest Income (Financial expense) 49.71%-10.42M35.15%-10.63M-5.63%-8.64M36.98%-3.01M-93.64%-20.71M4.77%-16.4M35.01%-8.18M33.81%-4.77M23.11%-10.7M-80.06%-17.22M
Research and development 2.86%149.14M0.18%112.84M3.93%74.28M6.62%36.32M7.42%145M11.36%112.64M10.40%71.47M13.18%34.07M11.46%134.98M15.28%101.15M
Credit Impairment Loss -22.17%-4.12M50.46%-1.71M78.10%-267.23K79.47%-400.52K-21.54%-3.38M-1.99%-3.45M-97.16%-1.22M-376.96%-1.95M-2,675.44%-2.78M-262.11%-3.38M
Asset Impairment Loss 34.55%-21.2M197.45%1.81M89.30%-199.34K-----76.79%-32.39M---1.86M---1.86M-----80.08%-18.32M----
Other net revenue 1,714.56%36.77M377.87%44.02M416.49%27.88M4,094.64%15.36M-112.42%-2.28M-19.06%9.21M-47.65%5.4M-93.20%366.19K11.92%18.34M-9.96%11.38M
Fair value change income 257.82%7.1M--3.03M--2.03M--1.25M315.39%1.99M-------------45.81%477.93K----
Invest income 4.28%14.89M42.75%9.06M79.80%6.3M2,083.07%3.35M43.42%14.28M469.62%6.35M236.84%3.5M21,442.94%153.45K44.15%9.96M200.91%1.11M
Asset deal income -----------------99.33%91.57K40.48%-14.22K-193.24%-15.01K--21.94K7,347.20%13.63M-115.86%-23.89K
Other revenue 134.03%40.1M288.54%31.83M300.86%20.02M421.16%11.16M11.48%17.14M-40.09%8.19M-49.44%4.99M-54.20%2.14M-16.83%15.37M4.75%13.67M
Operating profit 14.86%528.77M3.07%359.82M0.60%213.54M8.75%102.26M13.56%460.35M17.16%349.1M20.49%212.26M21.56%94.03M13.67%405.39M17.76%297.97M
Add:Non operating Income -23.32%2.12M-1.64%1.63M-25.10%773.91K4.53%536.01K-29.50%2.76M-7.74%1.66M-33.05%1.03M-32.44%512.79K-0.45%3.92M65.39%1.8M
Less:Non operating expense -62.46%790.67K-37.67%821.26K-36.58%712.32K-75.88%246.82K33.01%2.11M264.82%1.32M308.58%1.12M536.50%1.02M143.85%1.58M41.14%361.15K
Total profit 14.99%530.09M3.20%360.63M0.68%213.6M9.65%102.55M13.07%461M16.71%349.45M19.58%212.17M19.97%93.52M13.28%407.73M17.95%299.41M
Less:Income tax cost 25.80%58.83M2.09%53.53M-3.59%31.43M4.27%14.95M20.10%46.76M14.33%52.43M18.03%32.6M22.28%14.34M0.36%38.94M24.48%45.86M
Net profit 13.77%471.26M3.40%307.1M1.45%182.17M10.62%87.59M12.32%414.24M17.14%297.01M19.87%179.57M19.56%79.18M14.85%368.79M16.84%253.55M
Net profit from continuing operation 13.77%471.26M3.40%307.1M1.45%182.17M10.62%87.59M12.32%414.24M17.14%297.01M19.87%179.57M19.56%79.18M14.85%368.79M16.84%253.55M
Less:Minority Profit -43.34%3.51M-42.95%2.26M-21.33%2.01M-4.59%1.17M3.96%6.2M13.05%3.96M10.59%2.55M16.80%1.23M14.49%5.96M6.73%3.5M
Net profit of parent company owners 14.63%467.75M4.02%304.84M1.78%180.17M10.86%86.42M12.46%408.05M17.20%293.06M20.01%177.02M19.60%77.96M14.85%362.83M16.99%250.05M
Earning per share
Basic earning per share 13.43%0.764.17%0.50.00%0.297.69%0.1411.67%0.6714.29%0.4816.00%0.298.33%0.1315.38%0.60.00%0.42
Diluted earning per share 13.43%0.764.17%0.50.00%0.297.69%0.1411.67%0.6714.29%0.4816.00%0.298.33%0.1315.38%0.60.00%0.42
Other composite income
Total composite income 13.77%471.26M3.40%307.1M1.45%182.17M10.62%87.59M12.32%414.24M17.14%297.01M19.87%179.57M19.56%79.18M14.85%368.79M16.84%253.55M
Total composite income of parent company owners 14.63%467.75M4.02%304.84M1.78%180.17M10.86%86.42M12.46%408.05M17.20%293.06M20.01%177.02M19.60%77.96M14.85%362.83M16.99%250.05M
Total composite income of minority owners -43.34%3.51M-42.95%2.26M-21.33%2.01M-4.59%1.17M3.96%6.2M13.05%3.96M10.59%2.55M16.80%1.23M14.49%5.96M6.73%3.5M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now